2021 CMSC Annual Meeting

Author: Rachelle Ramirez

Late Breaking-Case Reports/Case Series

Brief Telehealth Screening of MS Patients in the Medical Setting

Background: A significant clinical need exists for a broad range of health care professionals to be able to objectively screen …...

Read More

Late Breaking-Disease-modifying therapy

Dimethyl Fumarate Is Associated with Lower Rates of Infection and Lower Infection-Related Healthcare Costs When Compared with Ocrelizumab

Background: Infections in people with multiple sclerosis (PwMS) may have a detrimental effect on disease progression, risk of...

Read More

Late Breaking-Disease-modifying therapy

B-Cell Depleters Attenuate the Humoral Response to Sars-Cov-2 Vaccines in Multiple Sclerosis Patients: A Case-Control Study

Background: B-cell depleting agents are FDA approved for the treatment of RRMS (ocrelizumab (OCR) and ofatumumab (OFA)) and PPMS...

Read More

Late Breaking-Disease-modifying therapy

Early Experience with Cladribine Tablets in an Aging Patient Population

Background: Cladribine, a deoxyadenosine analogue prodrug that preferentially depletes lymphocytes, may disrupt the central immune cascade...

Read More

Late Breaking-Disease-modifying therapy

Humoral and T-Cell Responses to Sars-Cov-2 Vaccination in Multiple Sclerosis Patients Treated with Ocrelizumab

Background: The COVID-19 epidemic raises important questions about the efficacy of vaccines for people treated with ocrelizumab (OCR), an...

Read More

Late Breaking-Disease-modifying therapy

US Real World Experience Switching from Infusion and S1P Therapies to Cladribine Tablets: A Single Center Study

Background: Multiple sclerosis (MS) is a chronic neurological disorder and a major cause of disability in young adults. Cladribine tablets...

Read More

Late Breaking-Psychosocial factors

Connect Trial of Online Professional Support Groups for Black and Latinx People Living with MS

Background: Given the high prevalence of anxiety and depression in MS, many patients struggle to find high quality, professional mental...

Read More

Late Breaking-Disease-modifying therapy

Variables Affecting Disease Modifying Therapy Adherence and Impact of Adherence on Multiple Sclerosis Patients (Egyptian experience)

Background: Multiple sclerosis (MS) is a chronic immune-mediated neurological disease affecting mainly young adults. MS patients are more...

Read More

Late Breaking-Self-care

Patient-Centered Education and Care Coordination Initiative to Improve Self-Management Skills in Latinos with Multiple Sclerosis

Background: Multiple sclerosis (MS) is a chronic, disabling neurological disease that attacks young adults. Similar to many other chronic...

Read More

Late Breaking-Case Reports/Case Series

Multiple Sclerosis Diagnosis: Challenges in Telehealth

Background: The COVID-19 pandemic ushered in a new era of telehealth to decrease transmission of the SARS-CoV-2 virus. While this …...

Read More